Meera Chappidi, MD, MPH

Title(s)ASST PROF IN RES, Urology
SchoolSchool of Medicine
Address400 Parnassus Avenue, #A632
San Francisco CA 94117
Phone415-885-7448
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The Johns Hopkins School of Medicine, Baltimore, MD M.D.05/2017Medicine
    The Johns Hopkins School of Public Health, Baltimore, MDM.P.H.05/2016Epidemiology & Biostatistics
    Brown University, Providence, RISc.B05/2012Neuroscience, Economics

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Role of MRI in Active Surveillance of Prostate Cancer. Semin Ultrasound CT MR. 2025 Feb; 46(1):31-44. Chappidi MR, Lin DW, Westphalen AC. PMID: 39608681.
      View in: PubMed   Mentions:    Fields:    
    2. Editorial Comment. J Urol. 2025 Feb; 213(2):190-191. Chappidi MR, Lin DW, de la Calle CM. PMID: 39508344.
      View in: PubMed   Mentions:    Fields:    
    3. Editorial Commentary. Urol Pract. 2025 Jan; 12(1):71-72. Chappidi MR, de la Calle CM. PMID: 39453975.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial. Clin Genitourin Cancer. 2024 Dec; 22(6):102223. Chappidi MR, Iravani A, Stambler N, Baskaran S, DiPippo VA, Denes BS, Lin DW. PMID: 39357459.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Editorial Commentary. Urol Pract. 2024 Nov; 11(6):938. Chappidi MR, Gore JL. PMID: 39196720.
      View in: PubMed   Mentions:    Fields:    
    6. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocols. Urol Oncol. 2023 08; 41(8):355.e19-355.e28. Chappidi MR, Escobar D, Meng MV, Washington SL, Porten SP. PMID: 37258373.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2023 01; 209(1):198-207. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons. J Urol. 2022 Mar; 207(3):534-540. Chappidi MR, Yang H, Meng MV, Bivalacqua TJ, Daneshmand S, Holzbeierlein JM, Kaimakliotis HZ, Konety B, Liao JC, Pohar K, Steinberg GD, Taylor JM, Tyson MD, Willard B, Lotan Y, Porten SP, Kates M. PMID: 34694916.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study. JNCI Cancer Spectr. 2021 10; 5(5). Marrone MT, Mondul AM, Prizment AE, Couper D, Barber JR, Chappidi MR, Joshu CE, Platz EA. PMID: 34738072; PMCID: PMC8562700.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. The erector spinae plane block can facilitate outpatient stone surgery by reducing breakthrough pain. BJU Int. 2021 11; 128(5):557-560. Yang H, Lee HH, Martin-Tuite P, Chappidi M, Bowman M, Hamouche F, Ahn J, Stoller M, Braehler M, Chi T. PMID: 34174145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort. Urology. 2021 10; 156:104-109. Chappidi MR, Welty C, Choi W, Meng MV, Porten SP. PMID: 34118229.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Live Renal Ultrasonography Facilitates Double-J Ureteral Stent Insertion at the Bedside: A Pilot Study for the COVID-19 Era. J Endourol. 2021 07; 35(7):1078-1083. Yang H, Chappidi M, Overland M, Ahn J, Bayne D, Chi T. PMID: 33261510; PMCID: PMC8336250.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Cost-Benefit Analysis of a Support Program for Nursing Staff. J Patient Saf. 2020 12; 16(4):e250-e254. Moran D, Wu AW, Connors C, Chappidi MR, Sreedhara SK, Selter JH, Padula WV. PMID: 28452914.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    16. Urethral Defect in Setting of Recurrent Urethral Foreign Body Insertion. Urology. 2020 Mar; 137:e12-e13. Simms A, Chappidi M, Yang H, Hampson L, Breyer B, Cohen AJ. PMID: 31794812.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Reply by Authors. J Urol. 2020 03; 203(3):552-553. Chappidi MR, Stimson CJ, Kates M, Odisho AY, Bivalacqua TJ. PMID: 31769720.
      View in: PubMed   Mentions:    Fields:    
    18. A Nationally Representative Study of Nonindex Hospital Readmissions following Radical Prostatectomy: Implications for Bundled Payment Models. J Urol. 2020 03; 203(3):546-553. Chappidi MR, Stimson CJ, Kates M, Odisho AY, Bivalacqua TJ. PMID: 31479405.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer. World J Urol. 2019 Dec; 37(12):2683-2689. Brant A, Daniels M, Chappidi MR, Joice GA, Sopko NA, Matoso A, Bivalacqua TJ, Kates M. PMID: 30850856.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology. World J Urol. 2019 Oct; 37(10):2051-2058. Gupta M, Milbar N, Tema G, Pederzoli F, Chappidi M, Kates M, VandenBussche CJ, Bivalacqua TJ. PMID: 30671639.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States. Transfusion. 2019 02; 59(2):500-507. Goel R, Patel EU, White JL, Chappidi MR, Ness PM, Cushing MM, Takemoto CM, Shaz BH, Frank SM, Tobian AAR. PMID: 30548491; PMCID: PMC6365172.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter? BJU Int. 2018 12; 122(6):1016-1024. Joice GA, Chappidi MR, Patel HD, Kates M, Sopko NA, Stimson CJ, Pierorazio PM, Bivalacqua TJ. PMID: 29897156.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA. 2018 02 27; 319(8):825-827. Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, Tobian AAR. PMID: 29486023; PMCID: PMC5838570.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    24. Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2017 Oct 27; 3(4):293-303. Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T, Sankin A, Pierorazio PM, Schoenberg MP, Bivalacqua TJ. PMID: 29152553; PMCID: PMC5676758.
      View in: PubMed   Mentions: 27  
    25. High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer. Bladder Cancer. 2017 Jul 27; 3(3):191-199. Kates M, Chappidi MR, Brant A, Milbar N, Sopko NA, Meyer C, Terezakis SA, Herman JM, Efron JE, Safar B, Tran PT, Ahuja N, Pierorazio PM, Bivalacqua TJ. PMID: 28824947; PMCID: PMC5545919.
      View in: PubMed   Mentions: 1  
    26. Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors. J Sex Med. 2017 08; 14(8):1059-1065. Pederzoli F, Chappidi MR, Collica S, Kates M, Joice GA, Sopko NA, Montorsi F, Salonia A, Bivalacqua TJ. PMID: 28709874.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance. BJU Int. 2017 12; 120(6):808-814. Tosoian JJ, Chappidi MR, Bishoff JT, Freedland SJ, Reid J, Brawer M, Stone S, Schlomm T, Ross AE. PMID: 28481440.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    28. Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database. BJU Int. 2017 09; 120(3):377-386. Chappidi MR, Kates M, Tosoian JJ, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM. PMID: 28418183.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database. J Sex Med. 2017 06; 14(6):810-817. Chappidi MR, Kates M, Sopko NA, Joice GA, Tosoian JJ, Pierorazio PM, Bivalacqua TJ. PMID: 28460994.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Prostate Health Index density improves detection of clinically significant prostate cancer. BJU Int. 2017 12; 120(6):793-798. Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Mamawala M, Agostino J, Carter HB, Partin AW, Sokoll LJ, Ross AE. PMID: 28058757.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    31. Author Reply. Urology. 2017 04; 102:158. Chappidi MR, Kates M, Bivalacqua TJ. PMID: 28131434.
      View in: PubMed   Mentions:    Fields:    
    32. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice. Prostate Cancer Prostatic Dis. 2017 06; 20(2):228-233. Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Agostino J, Macura KJ, Carter HB, Schaeffer EM, Partin AW, Sokoll LJ, Ross AE. PMID: 28117387; PMCID: PMC5429201.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    33. Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer. Urology. 2017 04; 102:148-158. Chappidi MR, Kates M, Brant A, Baras AS, Netto GJ, Pierorazio PM, Hahn NM, Bivalacqua TJ. PMID: 28104421; PMCID: PMC5376379.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy. J Urol. 2017 05; 197(5):1245-1250. Matulewicz RS, Tosoian JJ, Stimson CJ, Ross AE, Chappidi M, Lotan TL, Humphreys E, Partin AW, Schaeffer EM. PMID: 27916711.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy. Urol Oncol. 2017 02; 35(2):38.e17-38.e24. Chappidi MR, Chalfin HJ, Johnson DJ, Kates M, Sopko NA, Johnson MH, Liu JJ, Frank SM, Bivalacqua TJ. PMID: 27771280; PMCID: PMC5222715.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT? Urol Oncol. 2017 01; 35(1):34.e17-34.e25. Brant A, Kates M, Chappidi MR, Patel HD, Sopko NA, Netto GJ, Baras AS, Hahn NM, Pierorazio PM, Bivalacqua TJ. PMID: 27639777.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care. J Urol. 2017 02; 197(2):296-301. Chappidi MR, Kates M, Stimson CJ, Johnson MH, Pierorazio PM, Bivalacqua TJ. PMID: 27545575; PMCID: PMC5241219.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    38. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era. BJU Int. 2017 05; 119(5):676-683. Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ. PMID: 27367645.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    39. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012). Urol Oncol. 2016 12; 34(12):531.e15-531.e24. Chappidi MR, Kates M, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM. PMID: 27476032; PMCID: PMC5124513.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    40. Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative Sample. J Urol. 2017 01; 197(1):235-240. Chappidi MR, Kates M, Stimson CJ, Bivalacqua TJ, Pierorazio PM. PMID: 27460756; PMCID: PMC5161702.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    41. Accuracy of urethral frozen section during radical cystectomy for bladder cancer. Urol Oncol. 2016 12; 34(12):532.e1-532.e6. Kates M, Ball MW, Chappidi MR, Baras AS, Gordetsky J, Sopko NA, Brant A, Pierorazio PM, Epstein JI, Schoenberg MP, Bivalacqua TJ. PMID: 27432433.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol. 2016 06; 34(6):256.e1-6. Chappidi MR, Kates M, Patel HD, Tosoian JJ, Kaye DR, Sopko NA, Lascano D, Liu JJ, McKiernan J, Bivalacqua TJ. PMID: 26899289; PMCID: PMC4875870.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    Meera's Networks
    Concepts (165)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.